Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors
出版年份 2016 全文链接
标题
Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors
作者
关键词
-
出版物
ONCOGENE
Volume 35, Issue 42, Pages 5515-5526
出版商
Springer Nature
发表日期
2016-04-18
DOI
10.1038/onc.2016.92
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Activation of insulin-like growth factor receptor signaling mediates resistance to histone deacetylase inhibitors
- (2015) Jin-Soo Kim et al. CANCER LETTERS
- Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer
- (2015) Hye-Young Min et al. Molecular Cancer
- STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody
- (2015) Ji-Sun Lee et al. Nature Communications
- A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome
- (2014) Mark Kirschbaum et al. BRITISH JOURNAL OF HAEMATOLOGY
- Transcriptional and posttranslational regulation of insulin-like growth factor binding protein-3 by Akt3
- (2014) Quanri Jin et al. CARCINOGENESIS
- Epigenetic regulation of theIgf2/H19gene cluster
- (2014) M. Nordin et al. CELL PROLIFERATION
- The stem cell transcription factor ZFP57 induces IGF2 expression to promote anchorage-independent growth in cancer cells
- (2014) Y Tada et al. ONCOGENE
- Immunomodulatory Effects of Histone Deacetylase Inhibitors
- (2013) P.V. Licciardi et al. CURRENT MOLECULAR MEDICINE
- Combating Resistance to Anti-IGFR Antibody by Targeting the Integrin β 3-Src Pathway
- (2013) Dong Hoon Shin et al. JNCI-Journal of the National Cancer Institute
- JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles
- (2013) Anthony Mathelier et al. NUCLEIC ACIDS RESEARCH
- Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3
- (2013) J. C. Lui et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma
- (2012) Juanjuan Shan et al. HEPATOLOGY
- Insulin-like Growth Factor Receptor Inhibitors: Baby or the Bathwater?
- (2012) D. Yee JNCI-Journal of the National Cancer Institute
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation
- (2012) H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-like Growth Factor I Receptor Monoclonal Antibody
- (2011) D. H. Shin et al. MOLECULAR CANCER THERAPEUTICS
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- Insulin-like Growth Factor 2 Expression Modulates Taxol Resistance and Is a Candidate Biomarker for Reduced Disease-Free Survival in Ovarian Cancer
- (2010) G. S. Huang et al. CLINICAL CANCER RESEARCH
- Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study
- (2010) Anne M. Traynor et al. Journal of Thoracic Oncology
- Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells
- (2009) N. Eckstein et al. CANCER RESEARCH
- Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
- (2009) N. A. Dallas et al. CANCER RESEARCH
- CTCF: Master Weaver of the Genome
- (2009) Jennifer E. Phillips et al. CELL
- Hypoglycemia fromIGF2Overexpression Associated with Activation of Fetal Promoters and Loss of Imprinting in a Metastatic Hemangiopericytoma
- (2009) Elizabeth A. Lawson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma
- (2008) V. R. Fantin et al. CANCER RESEARCH
- JAK2/STAT2/STAT3 Are Required for Myogenic Differentiation
- (2008) Kepeng Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies
- (2008) Xiaodong Zhang et al. NATURE METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started